Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

NCT03057054

Conditions
Acute Graft Versus Host Disease, Hematologic Diseases, Hematopoietic and Lymphatic System Neoplasm, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

NCT05556720

Conditions
Blood Protein Disorders, COVID-19 Vaccines, Cardiovascular Diseases, +27 more
Locations
  • St Vincents Hospital Darlinghurst, New South Wales, Australia
  • Prince Of Wales Hospital Randwick, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Brisbane and Womens Hospital Herston, Queensland, Australia
View all 13 locations
View Trial Details
Active, Not Recruiting

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

NCT05878184

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +21 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Medical Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

NCT05831111

Conditions
DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +12 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • Noble Clinical Research Tucson, Arizona, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • Tekton Research Longmont, Colorado, United States
View all 34 locations
View Trial Details

Related conditions